HOME >> MEDICINE >> NEWS
Women on osteoporosis drug can discontinue use with no risk

A long-term study of the most widely used osteoporosis drug has found that many women can discontinue the drug after five years without increasing their fracture risk for as long as five more years.

The study on alendronate was led by researchers at the University of California, San Francisco, and findings are published in the December 27, 2006 issue of the "Journal of the American Medical Association." The research also showed that women at very high risk of painful spine fractures might be better-off continuing treatment.

"This has important implications as it has not been known whether treatment of osteoporosis should be continued indefinitely," said lead author Dennis Black, PhD, professor in the UCSF Department of Epidemiology and Biostatistics. "Because women with osteoporosis, particularly older post-menopausal women, often need to take multiple drugs, this would be welcome news for this group."

According to Black, shorter term studies of up to five years duration have shown reductions in fracture risk with alendronate treatment. This was the first study to examine the effects on fracture using the drug longer than five years, he said.

"We found that women who discontinued the drug had the same rate of non-spine fractures as women who continued using the drug," he said. "However, for clinically-recognized spine fractures, usually discovered due to back pain, continuing alendronate was better than discontinuing. And, if women choose to continue, we showed that 10 years of treatment is safe."

The new findings are from a follow-up study to the initial randomized trial that examined the effect of daily alendronate, a bisphosphonate or anti-resorptive drug, on bone mineral density and fracture risk in post-menopausal women with low BMD for up to 3.8 years.

Alendronate is used to reduce bone loss, increase bone density and reduce the risk of spine, wrist and hip fractures in postmenopausal women.
'"/>

Contact: Nancy Chan
nchan@pubaff.ucsf.edu
415-885-7277
University of California - San Francisco
26-Dec-2006


Page: 1 2 3

Related medicine news :

1. Women with migraines and visual symptoms may have higher stroke risk
2. Womens mortality rates for cardiovascular disease differ widely among hospitals
3. Women with breast cancer do not get potentially life-saving information, survey reveals
4. New health insurance survey -- Women have trouble affording care needed
5. Women without regular medical care at increased risk of ovarian cancer
6. Women need expanded musculoskeletal care during pregnancy, study finds
7. NHLBI awards 12 Womens Health Initiative contracts
8. Women need not wait to conceive after breast cancer
9. Women with rheumatoid arthritis have significantly less chance of remission than men
10. Women with mental disorders less likely to have mammograms
11. Alarming revelation: Women over 50 live in fear

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... VANCOUVER, Wash. (PRWEB) , ... January 10, 2020 , ... ... today announced their partnership in a new online community coming in February 2020, LEAD ... in the Health and Wellbeing Village. , The vision of LEAD WELL with WOMEN ...
(Date:1/10/2020)... ... 2020 , ... SMG3Rx, a clinical mobility platform powered by ... (Healthcare Information and Management Systems Society) Global Conference & Exhibition taking place on ... event of the year, where professionals throughout the global health ecosystem connect for ...
(Date:1/8/2020)... ... 2020 , ... Pyxa Solutions, a leading provider of consulting, ... is rebranding as Red Nucleus R&D, a division of Red Nucleus. Red Nucleus ... industry. , The addition of Red Nucleus R&D under the Red Nucleus ...
(Date:1/8/2020)... ... January 09, 2020 , ... Real ... Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata ... (RWD) to generate evidence and identify gaps and challenges when conducting trials? The ...
(Date:1/7/2020)... Texas (PRWEB) , ... January 07, 2020 , ... ... today unveiled another facility expansion, adding to the company’s 200,000 sq. ft. manufacturing ... 25,000 sq. ft. of manufacturing space dedicated to POD architectural, mechanical, electrical and ...
Breaking Medicine News(10 mins):
(Date:1/22/2020)... ... January 22, 2020 , ... Clairvoyant Networks, ... Care GPS remote monitoring and communications technology was selected for demonstration in the ... showcases the latest technology and services for consumers and businesses needing solutions that ...
(Date:1/12/2020)... ... January 10, 2020 , ... ... has been selected to present at next week’s Biotech Showcase. Cytonus is ... with its proprietary Cargocyte™ next generation Adoptive Cellular Therapy (ACT) technologies which ...
(Date:1/10/2020)... ... January 10, 2020 , ... Reach ... Counselor Association, will celebrate high school counselors and award the first annual Excellence ... National Championship weekend and Extra Yard for Teachers Summit celebration on Saturday, January ...
Breaking Medicine Technology:
Cached News: